SCYNEXIS, Inc. (NASDAQ: SCYX) is a publicly traded biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. We are developing our lead asset, ibrexafungerp (formerly known as SCY-078), as a broad-spectrum, systemic antifungal for multiple fungal indications in both the community and hospital settings. The New Drug Application (NDA) for BREXAFEMME® (ibrexafungerp tablets) was approved by the U.S. Food and Drug Administration (FDA) on June 1, 2021. For more information, visit www.brexafemme.com. We are also continuing late-stage clinical development of ibrexafungerp for the prevention of recurrent VVC as well as the treatment of life-threatening invasive fungal infections in hospitalized patients.

Ibrexafungerp, the first representative of a novel class of antifungals, is poised to bring significant innovation to the vaginal yeast infection space. There has been no new oral product for over 25 years and healthcare providers are eager to have an alternative to treat their patients. Our passion for the patient is the core foundation of our company and we use our resourceful mindset to drive our efficiency. The company is building its commercial organization and has initiated activities for the H2:2021 launch of Ibrexafungerp in vaginal yeast infections.

We are seeking a highly motivated Clinical Trial Associate, to be based in our Jersey City, NJ offices 2 days a week (flexible schedule for the ideal candidate). We are committed to positively impacting the lives of patients by developing innovative therapies, come join us and make a difference.

Position Summary:

The Clinical Trial Associate (CTA) provides administrative and study operational support to the clinical study team(s) responsible for clinical trial execution. The ideal candidate will support internally sourced studies and/or studies outsourced to Clinical Research Organizations (CROs) and other third parties. This position reports to the Senior Clinical Study Manager.

Responsibilities:

• Organize and deliver analyzable reports and metrics to the clinical study leader.
• Schedule and coordinate meetings, prepare agendas, presentation materials and minutes for clinical study team meetings and other study related meetings.
• Collate data for assessments such as feasibility and site selection.
• Contribute to review of study documents such as informed consent forms, case report forms, study manuals/procedures and facilitate study document reviews.
• Coordinate materials for trainings and investigator meetings.
• Track site activation, enrollment, and monitoring visits to projected plans, and escalate any issues or delays with site activation or deviations from monitoring plan.
• Review monitoring reports as assigned by study manager.
• Directly communicate with CRO & vendors.
• Create and maintain study/project files.
• Collect and query for missing documents from CRO or sites, upload of documents to the eTMF if internal eTMF is used or review/audit CRO eTMF to ensure it is updated per expectations.
• Review and help take actions using Excel tracking sheets as needed (List of investigators, List of active sites, DSURs approvals, Information about ethics committees, tracking of trial approvals expiration dates etc.)
• Maintain site personnel contact list.
• Maintain key study documents on sponsor internal repository.

Requirements and Preferred Skills:

• Associate degree with a minimum of 2+ years of relevant experience in a Life Sciences, pharmaceutical and/or CRO organization.
• Bachelor’s degree preferred.
• Excellent written and verbal communication skills.
• Strong customer service skills and ability to work effectively with vendors and sites.
• Ability to manage multiple projects and timelines simultaneously.
• Ability to prioritize tasks, follow up, and resolve meaningfully.
• Excellent organizational skills and attention to detail are required.
• Strong proofreading, editing, and reviewing skills are needed.
• Must be able to work independently, proactively provide meaningful and timely updates, and participate in meetings and possess problem solving skills.
• Basic knowledge of drug development and FDA GCP/ICH regulatory guidelines.
• Familiarity with DIA TMF Reference Model is preferred.
• Strong skills with Microsoft Excel, Word, Power point required.
• Occasional travel may be required (5-10%) to attend business meetings with vendors or participate in investigator meetings.
• Employment is contingent upon satisfactory results of a pre-employment background check, drug screen and proof of full COVID-19 vaccination.

For more information about SCYNEXIS, please visit https://www.scynexis.com.

An Equal Opportunity Employer

SCYNEXIS, Inc. (NASDAQ: SCYX) is a publicly traded biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. We are developing our lead asset, ibrexafungerp (formerly known as SCY-078), as a broad-spectrum, systemic antifungal for multiple fungal indications in both the community and hospital settings. The New Drug Application (NDA) for BREXAFEMME® (ibrexafungerp tablets) was approved by the U.S. Food and Drug Administration (FDA) on June 1, 2021. For more information, visit www.brexafemme.com. We are also continuing late-stage clinical development of ibrexafungerp for the prevention of recurrent VVC as well as the treatment of life-threatening invasive fungal infections in hospitalized patients.

Ibrexafungerp, the first representative of a novel class of antifungals, is poised to bring significant innovation to the vaginal yeast infection space. There has been no new oral product for over 25 years and healthcare providers are eager to have an alternative to treat their patients. Our passion for the patient is the core foundation of our company and we use our resourceful mindset to drive our efficiency. The company is building its commercial organization and has initiated activities for the H2:2021 launch of Ibrexafungerp in vaginal yeast infections.

We are seeking an experienced Clinical Study Manager, to be based in our Jersey City, NJ offices 2 days a week (flexible schedule for the ideal candidate). We are committed to positively impacting the lives of patients by developing innovative therapies, come join us and make a difference.

Position Summary:

The Clinical Study Manager will support the implementation of assigned clinical trials for SCYNEXIS. This position will have hands-on responsibility and strategic oversight on the planning and execution of clinical activities related to the assigned clinical study centers/regions.

Responsibilities may include operational management of one or more cross-functional study team(s) and/or performance and quality oversight of one or more Contract Research Organization (CRO) teams and other vendors.

Responsibilities:

• Key contributor to the Clinical Operations team responsible for the planning and execution of assigned clinical trials that meet the standards of excellence for ethics, scientific merit, and regulatory compliance, in line with corporate goals for approval of products.
• Participate in the selection of CROs and other vendors to support clinical study operations centers.
• Oversee required country regulatory (e.g. FDA, MoH) and country/site IRB/IEC approvals/notifications.
• Oversee clinical monitoring quality and adherence to established processes and plans.
• Manage the budget and resources allocated to the assigned clinical development activities.
• Establish productive, interactive relationships with key internal departments.
• Manage consultants and collaborators under their responsibility.
• Lead/support the cross-functional global team for execution of the study and be the primary operational contact for the study.
• Liaise with and provide information to regulatory affairs as required.
• Collaborate with the pharmaceutical development team to ensure proper planning and distribution of clinical trial supplies.
• Support/provide input into the writing of protocols, protocol amendments, informed consents, clinical study reports, initial IND and annual IND updates, investigators brochure and updates, etc.
• Provide operational and strategic input into study documents and/or lead development of these documents such as the Monitoring Plan, CRFs, CRF Completion Guidelines, Study Execution Plans, Clinical Data Review Plan, Clinical Database edit specifications, Clinical Study Report (CSR) development, etc.
• Inform team members and leadership (as appropriate) on overall clinical trial plans, updated forecasting, and of potential issues/mitigation.
• Participate in the development of SOPs, facilitate training and ensure compliance for the team under his/her supervision.
• Additional duties and responsibilities that may be assigned from time to time.

Requirements and Preferred Skills:

• Minimum Bachelor’s Degree in Science Discipline (Healthcare Degree Preferred).
• 4+ years of current pharma / biotech experience, including Clinical Development and/or Clinical Operations with a minimum of 2 years clinical study management experience.
• Experience considered relevant includes clinical research in a pharmaceutical company, a Medical device/Diagnostic company, Academic Research Organization (ARO) or Contract Research Organization (CRO). CRA experience is preferred, Clinical study management skills are required. Time spent directly in a medical environment (e.g. as a Study Site Coordinator) is preferred.
• Therapeutic Area Experience such as infectious diseases is preferred (e.g., invasive fungal infections). Other therapeutic area experiences will also be considered.
• Knowledge of Good Clinical Practices (GCP), FDA regulations and guidelines, and applicable international regulatory requirements.
• Vendor management experience.
• Project and vendor management, analytical and problem-solving skills.
• Effective verbal and written communication and interpersonal skills.
• Ability to quickly adapt to and manage an environment with rapidly changing organizational needs
• Ability to travel domestically up to 20% if needed. Occasional international travel may be required to participate in investigator meetings, SIVs, or conferences.
• Employment is contingent upon satisfactory results of a pre-employment background check, drug screen and proof of full COVID-19 vaccination.

For more information about SCYNEXIS, please visit https://www.scynexis.com.

An Equal Opportunity Employer

SCYNEXIS, Inc. (NASDAQ: SCYX) is a publicly traded biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. We are developing our lead asset, ibrexafungerp (formerly known as SCY-078), as a broad-spectrum, systemic antifungal for multiple fungal indications in both the community and hospital settings. The New Drug Application (NDA) for BREXAFEMME® (ibrexafungerp tablets) was approved by the U.S. Food and Drug Administration (FDA) on June 1, 2021. For more information, visit www.brexafemme.com. We are also continuing late-stage clinical development of ibrexafungerp for the prevention of recurrent VVC as well as the treatment of life-threatening invasive fungal infections in hospitalized patients.

Ibrexafungerp, the first representative of a novel class of antifungals, is poised to bring significant innovation to the vaginal yeast infection space. There has been no new oral product for over 25 years and healthcare providers are eager to have an alternative to treat their patients. Our passion for the patient is the core foundation of our company and we use our resourceful mindset to drive our efficiency. The company is building its commercial organization and has initiated activities for the H2:2021 launch of Ibrexafungerp in vaginal yeast infections.

We are seeking a highly motivated Commercial Coordinator, to be based in our Jersey City, NJ offices 2-3 days a week (flexible schedule for the ideal candidate). We are committed to positively impacting the lives of patients by developing innovative therapies, come join us and make a difference.

Position Summary:

The Commercial Coordinator will work closely with the commercial sales and marketing leadership team to support day to day field sales operations. In addition, coordinate the completion of grant requests and speaker programs.

The ideal candidate must be a self-starter, organized and able to manage multiple priorities. This position reports to the Chief Commercial Officer.

Responsibilities:

• Support the Commercial leadership team with grant request and speaker programs.
• Provide updated details on progress of requests that are submitted to the Commercial teams.
• Plan and organize field sales meetings.
• Create presentations in PowerPoint, manage meeting notes and team deliverables.
• Reconcile invoices from third-party vendors. Review and process payments ensuring appropriate amount is billed, tracking of payments, and working with Accounts Payable and vendor in resolving discrepancies.
• Manage expense reports for the team and ensure reconciliation of expenses.
• Assist with onboarding new hires. Initiating equipment and office set up, preparing necessary documents for training.
• Administrative support as needed which include, but not limited to, travel and calendar management.
• Additional projects or assignments as needed.

Requirements and Preferred Skills:

• BS in Business Administration or related field.
• A minimum of two years field sale coordinator experience, pharma industry preferred.
• Proficient in MS Office Suite: Outlook, Word, Excel, PowerPoint, and Internet.
• Strong interpersonal skills, flexible, detail-oriented, and professional.
• Comfortable in a start-up environment.
• Solid organizational skills, including multitasking and time-management.
• Strong client-facing and teamwork skills.
• Familiar working with commercial sales and marketing teams based in field locations in the US.
• Employment is contingent upon satisfactory results of a pre-employment background check, drug screen and proof of full COVID-19 vaccination.

For more information about SCYNEXIS, please visit https://www.scynexis.com.

An Equal Opportunity Employer

SCYNEXIS, Inc. (NASDAQ: SCYX) is a publicly traded biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. We are developing our lead asset, ibrexafungerp (formerly known as SCY-078), as a broad-spectrum, systemic antifungal for multiple fungal indications in both the community and hospital settings. The New Drug Application (NDA) for BREXAFEMME® (ibrexafungerp tablets) was approved by the U.S. Food and Drug Administration (FDA) on June 1, 2021. For more information, visit www.brexafemme.com. We are also continuing late-stage clinical development of ibrexafungerp for the prevention of recurrent VVC as well as the treatment of life-threatening invasive fungal infections in hospitalized patients.

Ibrexafungerp, the first representative of a novel class of antifungals, is poised to bring significant innovation to the vaginal yeast infection space. There has been no new oral product for over 25 years and healthcare providers are eager to have an alternative to treat their patients. Our passion for the patient is the core foundation of our company and we use our resourceful mindset to drive our efficiency. The company is building its commercial organization and has initiated activities for the H2:2021 launch of Ibrexafungerp in vaginal yeast infections.

We are seeking an experienced Director, Revenue Accounting, to be based in our Jersey City, NJ offices 2-3 days a week (flexible schedule for the ideal candidate). We are committed to positively impacting the lives of patients by developing innovative therapies, come join us and make a difference.

Position Summary:

The Director, Revenue Accounting position will manage the Revenue Recognition process, including partnering with various commercial teams. In addition, this person will lead various system interface activities and reconcile Gross-To-Net transactions. This is a newly created position reporting to the Executive Director, Finance and Corporate Controller and is an opportunity to contribute significantly to a top-tier, rapidly growing, public company.

The successful candidate will be action-oriented with a blend of both technical and operational accounting experience related to revenue recognition and can build strong relationships with and deliver superior service to all key stakeholders.

Responsibilities:

• Lead and establish revenue recognition policy for the company and be the subject matter expert in revenue-related matters.
• Review revenue contracts and assess the accounting and reporting implications in accordance with ASC 606 and validate pricing set up in the system.
• Draft technical accounting memos related to ASC 606. Assist in the preparation of SEC filings and interface with external auditors and BDO as needed. Ensure proper revenue recognition in accordance with applicable guidance and ensure consensus with external auditors.
• Collaborate and support with various business partners, such as Contracting, Trade, Reimbursement, Sales, FP&A teams.
• Manage and reconcile Gross-To-Net (GTN) system setups as well as 3PL system and GTN system interfaces.
• Manage claim processing vendors (chargeback, rebates, copay and others) to ensure accuracy and timeliness of claim data (unit and amount) and payments; supervise the month-end and quarter-end revenue close process activities, including review of journal entries, data interface validation and review of account reconciliations and analyses.
• Lead systems and process improvement processes for revenue accounting & AR processes, including instant data reporting, streamlining and reconciliation processes; Liaise with external auditors during quarterly review and annual audit; ensure SOX compliance of Revenue Cycle; support SEC Disclosure requirements with respect to ASC 606 reporting requirements.
• Handle specific ad-hoc projects as needed.

Requirements and Preferred Skills:

• Bachelor's Degree in Accounting or Finance; Master’s degree is a plus.
• CPA Preferred.
• Minimum 10 years of prior experience in a public accounting firm and/or public company environment.
• 3+ years of Commercial Pharma experience required, specifically in a Revenue Accounting function.
• Extensive experience with ASC 606 revenue recognition in biotech and pharmaceutical industries.
• Experience with financial and accounting reporting systems; Great Plains is a plus.
• Proficient in system interfaces and data analysis & reconciliation.
• Ability to stay knowledgeable about, research and reach well-reasoned conclusions on technical accounting issues.
• Highly organized and detailed; ability to work within deadlines in a fast-paced growing environment.
• Employment is contingent upon satisfactory results of a pre-employment background check, drug screen and proof of full COVID-19 vaccination.

For more information about SCYNEXIS, please visit https://www.scynexis.com.

An Equal Opportunity Employer

SCYNEXIS, Inc. (NASDAQ: SCYX) is a publicly traded biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. We are developing our lead asset, ibrexafungerp (formerly known as SCY-078), as a broad-spectrum, systemic antifungal for multiple fungal indications in both the community and hospital settings. The New Drug Application (NDA) for BREXAFEMME® (ibrexafungerp tablets) was approved by the U.S. Food and Drug Administration (FDA) on June 1, 2021. For more information, visit www.brexafemme.com. We are also continuing late-stage clinical development of ibrexafungerp for the prevention of recurrent VVC as well as the treatment of life-threatening invasive fungal infections in hospitalized patients.

Ibrexafungerp, the first representative of a novel class of antifungals, is poised to bring significant innovation to the vaginal yeast infection space. There has been no new oral product for over 25 years and healthcare providers are eager to have an alternative to treat their patients. Our passion for the patient is the core foundation of our company and we use our resourceful mindset to drive our efficiency. The company is building its commercial organization and has initiated activities for the H2:2021 launch of Ibrexafungerp in vaginal yeast infections.

We are seeking an experienced Director, Sales Force Effectiveness, to be based in our Jersey City, NJ offices 2-3 days a week (flexible schedule for the ideal candidate). We are committed to positively impacting the lives of patients by developing innovative therapies, come join us and make a difference.

Position Summary:

The Director of Sales Force Effectiveness (DSFE) will enhance the productivity and impact of the customer facing teams, as well as ensure strategy & tactics align to the needs of the business.

Reporting to the Chief Commercial Officer (CCO), the ideal candidate must have relevant successful sales experience, sales training experience (development & execution), and experience working closely with senior commercial leaders to support & evaluate the effectiveness of customer facing teams.

The DSFE will be responsible for driving key strategic projects in the areas of Sales Force Effectiveness and partner with sales, marketing, and operations to recommend, develop & execute training programs across all customer facing teams.

Responsibilities:

• Collaborate with Head of Sales and District Sales Managers to:
  • Identify process improvements and tools needed to maximize field performance and productivity.
  • Create sustainable professional development programs and plans.
  • Help ensure company commercial and compliance processes are adhered to.
  • Develop onboarding program & materials to support ongoing training across all customer facing teams.
  • Develop assessments to identify gaps in people, processes, and plans; provide recommendations to help with these areas to sales leaders.
• Ensures the training team understands the evolving business challenges that impact customer/company performance in their day-to-day activities; assists them in identifying solutions and addressing these challenges.
• Lead assessments of critical sales capabilities and ensure sales effectiveness aligned to company goals.
• Recommend to CCO areas to optimize and ensure effective & efficient execution across all customer facing teams.
• Support the high-performance commercial culture with recommendations for future improvements.
• Ensure consistency in sales force processes and day to day activities to improve accuracy of sales analytics.

Requirements and Preferred Skills:

• Bachelor’s Degree required, relevant field (Business or Medical preferred).
• At least 10+ years of commercial experience, ideally in the biotech and/or pharmaceutical industry.
• Prior experience with recently launching brands/products; drugs in infectious disease, women’s health and hospital preferred.
• Proven track record of field roles and learning & development.
• Sophisticated mix of emotional intelligence, judgment, discretion, diplomacy, and business acumen
• Possess a strong understanding of the industry, competitors, and technology and what is required for sustained field results.
• Demonstrated experience planning, designing, and implementing Salesforce Improvement solutions.
• Ability to thrive in a fast-paced, innovative environment while remaining flexible, proactive, resourceful, and efficient.
• Experience in building commercial infrastructure and teams from the ground up.
• Skilled in communicating complex information to a variety of audiences; demonstrated ability to break down complex ideas and concepts in the biotech/ pharmaceutical and/ or healthcare industry in easy-to-understand ways.
• Strong written, presentation, creative and meeting facilitation skills.
• Excellent project management abilities, follow-through, attention to detail and timeliness.
• Employment is contingent upon satisfactory results of a pre-employment background check, drug screen and proof of full COVID-19 vaccination.

For more information about SCYNEXIS, please visit https://www.scynexis.com.

An Equal Opportunity Employer

SCYNEXIS, a publicly-traded company (NASDAQ:SCYX), is pioneering a new class of antifungal medicines to help millions of patients worldwide in need of new options to overcome and prevent difficult-to-treat and drug resistant infections. Our lead candidate, ibrexafungerp, is a broad-spectrum, intravenous (IV)/oral agent in late-stage development for multiple indications, ranging from the treatment of vaginal yeast infections in the community setting to life-threatening invasive fungal infections in hospitalized patients. Ibrexafungerp, the first oral representative of a novel class of antifungals, is positioned to bring significant innovation to the vaginal yeast infection space. There has been no new oral product for over 25 years and healthcare providers are eager for a novel alternative to treat their patients. Our passion for the patient is the core foundation of our company and we use our resourceful mindset to drive our efficiency. The company is building its commercial organization and has initiated activities for the H2:2021 launch of Ibrexafungerp in vaginal yeast infections.

We are seeking an experienced Manager, Financial Planning & Analysis (FP&A) to be based in our Jersey City, NJ offices 2-3 days a week (flexible schedule for the ideal candidate). We are committed to positively impacting the lives of patients by developing innovative therapies, come join us and make a difference.

Position Summary:

The Manager, FP&A position will coordinate the profitability, budgeting and forecasting for our global business. This is a newly created position reporting to the Executive Director, Finance and Corporate Controller and is an opportunity to contribute significantly to a top-tier, rapidly growing, public company.

The successful candidate will be action-oriented with a blend of both strategic and operational FP&A experience related to general finance procedures and who can build strong relationships with and deliver superior service to all key stakeholders.

Responsibilities:

• Provide financial analysis and support to operating managers on strategic planning, budgeting, and operations planning, performance monitoring and variance analysis to ensure accurate or complete reporting.
• Support preparation of internal management reports and comprehensive analyses of financial and statistical results to support operations and senior management.
• Distribute management financials and analytics to business operations and schedule actual vs budget review meetings with department heads on a regular basis and finalize quarterly accrual process.
• Assist in preparation of the annual budget and quarterly rolling forecasts and deliver standard financial reports specific for operations on a regular basis.
• Manage strategic planning, budgeting, and forecasting procedures/policies for the organization.
• Ensure adjacent financial processes are compliant with applicable company policies.
• Support Ad Hoc requests from the business and operations, (i.e., spending trend analysis, payment trend analysis, historical financial information) to enhance operational efficiency.
• Ensure all reports are prepared with a high level of responsiveness to customer needs, requiring the quick turnaround of available data into a useful story.
• Interface with associates across a wide horizontal and vertical spectrum within the organization to answer questions about financial projections, reported results, key drivers and leading indicators, as well as disseminate financial information.
• Build and maintain relationships with cross-functional teams and finance business partners to synthesize and integrate updates relating to budget and planning.
• Work closely with Revenue Accounting team to analyze actual vs forecast variances.

Requirements and Preferred Skills:

• Bachelor's Degree in Accounting or Finance. MBA a plus.
• 5 years’ experience in FP&A or related experience. Branded Pharma experience preferred.
• Strong hands-on experience with Gross to Net, R&D, G&A and Capex forecasting.
• Knowledge of the principles, processes and standards for integrated financial analysis and reporting.
• Experience with budgeting systems; Centage budgeting application is a plus.
• Highly proficient in Microsoft Office including advanced Excel with proven experience in building Excel models and reporting packages.
• Ability to lead and coordinate forecast activities across different business functions.
• Excellent communication and presentation skills.
• Highly organized and detailed; ability to work within deadlines in a fast-paced growing environment.
• Employment is contingent upon satisfactory results of a pre-employment background check, drug screen and proof of full COVID-19 vaccination.

For more information about SCYNEXIS, please visit https://www.scynexis.com.

An Equal Opportunity Employer

SCYNEXIS, a publicly-traded company (NASDAQ:SCYX), is pioneering a new class of antifungal medicines to help millions of patients worldwide in need of new options to overcome and prevent difficult-to-treat and drug resistant infections. Our lead candidate, ibrexafungerp, is a broad-spectrum, intravenous (IV)/oral agent in late-stage development for multiple indications, ranging from the treatment of vaginal yeast infections in the community setting to life-threatening invasive fungal infections in hospitalized patients. Ibrexafungerp, the first oral representative of a novel class of antifungals, is positioned to bring significant innovation to the vaginal yeast infection space. There has been no new oral product for over 25 years and healthcare providers are eager for a novel alternative to treat their patients. Our passion for the patient is the core foundation of our company and we use our resourceful mindset to drive our efficiency. The company is building its commercial organization and has initiated activities for the H2:2021 launch of Ibrexafungerp in vaginal yeast infections.

We are seeking a highly motivated Senior Accounting Analyst to be based in our Jersey City, NJ offices with flexible schedule for the ideal candidate. We are committed to positively impacting the lives of patients by developing innovative therapies, come join us and make a difference.

Position Summary:

The Senior Accounting Analyst position will perform a variety of accounting activities in accordance with accounting principles and standards related to revenue accounting, general ledger, and projects. This role will provide a well-qualified and energetic candidate with a diverse experience within the finance function that allows a candidate to learn about the commercial business and pharmaceutical operations while leveraging their accounting and finance knowledge. This is a newly created position reporting to the Director, Revenue Accounting and is an opportunity to contribute significantly to a top-tier, rapidly growing, public company.

Responsibilities:

• Perform monthly accounting close for Gross to Net line items including direct/indirect discounts, rebates, and other deductions.
• Participate in the GTN reserve analysis process to ensure reserves are properly stated, risks are identified and mitigated, and GTN rates are appropriately captured.
• Track all Gross to Net related contracts and actual payments in a timely manner.
• Perform account variance analysis for utilization, rate, and price.
• Perform account reconciliation, GTN financial reporting and ad hoc analysis.
• Collaborate with Market Access and Finance teams to ensure components contemplated in the GTN revenue accounting are accurate and complete.
• Support GTN budgeting and forecasting process by reviewing and providing supporting data models.
• Provide support and analysis for internal and external auditors.
• Coordinate month end and quarter end close meetings with internal teams.
• Update and maintain Standard Operating Procedures and Check list for GTN activities.

Requirements and Preferred Skills:

• Bachelor's Degree in Accounting or Finance.
• CPA/MBA a plus.
• 3 years’ experience in pharmaceutical Gross to Net Accounting, Market Access contracting, Government Pricing or Commercial Analytics.
• Brand Pharma and rebate claim experience preferred.
• Advance skills in Microsoft Excel (including pivot tables, VLOOKUP and macros).
• Tableau and financial reporting tools a plus.
• Ability to handle large volume of complex data.
• Highly organized and detailed; ability to work within deadlines in a fast-paced growing
• Employment is contingent upon satisfactory results of a pre-employment background check, drug screen and proof of full COVID-19 vaccination.

For more information about SCYNEXIS, please visit https://www.scynexis.com.

An Equal Opportunity Employer

SCYNEXIS, Inc. (NASDAQ: SCYX) is a publicly traded biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. We are developing our lead asset, ibrexafungerp (formerly known as SCY-078), as a broad-spectrum, systemic antifungal for multiple fungal indications in both the community and hospital settings. The New Drug Application (NDA) for BREXAFEMME® (ibrexafungerp tablets) was approved by the U.S. Food and Drug Administration (FDA) on June 1, 2021. For more information, visit www.brexafemme.com. We are also continuing late-stage clinical development of ibrexafungerp for the prevention of recurrent VVC as well as the treatment of life-threatening invasive fungal infections in hospitalized patients.

Ibrexafungerp, the first representative of a novel class of antifungals, is poised to bring significant innovation to the vaginal yeast infection space. There has been no new oral product for over 25 years and healthcare providers are eager to have an alternative to treat their patients. Our passion for the patient is the core foundation of our company and we use our resourceful mindset to drive our efficiency. The company is building its commercial organization and has initiated activities for the H2:2021 launch of Ibrexafungerp in vaginal yeast infections.

We are seeking an experienced Senior Director, Quality Assurance, to be based in our Jersey City, NJ offices 2-3 days a week (flexible schedule for the ideal candidate). We are committed to positively impacting the lives of patients by developing innovative therapies, come join us and make a difference.

Position Summary:

The Sr. Director, Quality Assurance is responsible for providing leadership for all GxP Quality Assurance activities including overseeing the daily activities of the Quality Assurance function. This role will assure appropriate oversight of Quality Assurance activities internally at SCYNEXIS and those of vendors providing GxP services to the company to ensure compliance for early phase development products through commercial products. This role reports to the Vice President of Regulatory Affairs and Quality Assurance.

Responsibilities:

• Lead the company’s Quality Assurance program to provide appropriate oversight of research and development, manufacturing, and pharmacovigilance activities.
• Provide continual guidance on improvement and maintenance of a compliant Quality Management System.
• Provide technical expertise and guidance to the organization by supporting and/or managing deviations, CAPA investigations, SOPs, document control and training.
• Work effectively and collaboratively with external vendors and cross-functional teams, such as pharmaceutical development, manufacturing, commercial, supply chain, quality control, regulatory affairs, and program management.
• Provide guidance functionally and cross-functionally.
• Manage work activities of peers and contractors for specific projects or objectives as required.
• Support the quality organization in developing, implementing, and maintaining Quality Systems for oversight of CMOs, CROs, CPOs, 3PLs and contract labs. Establish metrics and process indicators to drive compliance and continuous improvement.
• Manage competing priorities to meet departmental and organizational targets and timelines.
• Work across all disciplines to ensure that the company maintains a state of readiness for GxP inspections by regulatory agencies. Ensure training of all GxP personnel.
• Promote a culture of quality and operational excellence.

Requirements and Preferred Skills:

• Advanced degree in a Life Science or related discipline required, Masters Degree or PhD.
• A minimum of 10 years of relevant experience in at least one of the GxP focus areas with additional direct experience in the other GxP areas.
• Strong experience in a Quality Operations Leadership role.
• In depth understanding and application of GxP, industry standards, International Regulations and Guidelines, and Inspection Readiness Programs in pharma and/or biotech industry.
• Extensive experience with internal and external audits.
• Strong interpersonal skills: the ability to interact effectively with all levels within the organization, third parties, and regulatory authorities.
• Exceptional writing and oral presentation skills required.
• Excellent project management and decision-making skills.
• Excellent interpersonal, verbal, and written communication skills are essential in this collaborative position
• Comfortable in a fast-paced small company environment and able to adjust workload based upon changing priorities.
• Able to influence and negotiate professionally at various levels within the project team and with external partners while maintaining positive working relationships.
• Employment is contingent upon satisfactory results of a pre-employment background check, drug screen and proof of full COVID-19 vaccination.

For more information about SCYNEXIS, please visit https://www.scynexis.com.

An Equal Opportunity Employer